Improved immune activation markers in chronic fatigue and immune dysfunction syndrome (CFIDS) patients treated with thymic protein A

Journal of Nutritional and Environmental Medicine

Volumn 11, Issue 4, 2001, Pages 241-247

  Rosenbaum, Michael E ^a   Vojdani, Aristo ^b   Susser, Murray ^c   Watson, Cynthia M ^d  

^a Immunosciences Laboratory Inc ^*

^b Immunosciences Laboratory Inc

^c Longevity Medical Center   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Chronic fatigue; Immune regulation; Oral treatment; Thymic protein

Indexed keywords

BIOCHEMICAL MARKER; CD8 ANTIGEN; IMMUNOMODULATING AGENT; INTERFERON; THYMIC PROTEIN A; THYMUS PEPTIDE; UNCLASSIFIED DRUG;

ARTICLE; BLOOD ANALYSIS; CELL SUBPOPULATION; CHRONIC FATIGUE SYNDROME; CLINICAL ARTICLE; DRUG EFFECT; ENZYME BLOOD LEVEL; HUMAN; IMMUNE DEFICIENCY; IMMUNE DYSFUNCTION SYNDROME; IMMUNOREGULATION; NATURAL KILLER CELL; PRIORITY JOURNAL; SYMPTOMATOLOGY;

EID: 0035690246     PISSN: 13590847     EISSN: None     Source Type: Journal    
DOI: 10.1080/13590840120103085     Document Type: Article

References (24)

1. The chronic fatigue syndrome: A comprehensive approach to its definition and study
2. Chronic fatigue and immune dysfunction
3. Viral studies of chronic fatigue syndrome
4. Decreased natural killer cell activity is associated with severity of chronic fatigue dysfunction syndrome
5. Immunological abnormalities associated with chronic fatigue syndrome
6. Upregulation of the 2-5A synthetase/RNase L antiviral pathway associated with chronic fatigue syndrome
7. Immunopotentiating and immunotherapeutic effects of thymic hormones and factors with special emphasis on thymic humoral factor THF-Y2
8. Induction of T cell maturation by a cloned line of thymic epithelium (TEPI)
9. Immunologic effects of human thymic stromal grafts and cell lines
10. Studies on the chemistry of anaphylaxis III: Experiments with isolated proteins, especially those of the hens egg
11. Intestinal absorption of undegraded protein in men: Presence of bromelain in plasma after oral intake
12. Systemic immunological changes induced by administration of grass pollen allergens via the oral mucosa during sublingual immunotherapy
13. Insulin in oral "tolerance": A one-amino acid change in the B chain makes the difference
14. Downregulation of RNase L inhibitor correlates with upregulation of interferon-induced proteins (2-5A Synthetase and RNase L) in patients with chronic fatigue immune dysfunction syndrome
15. Regulation of the natural killer receptor repertoire
16. Interferon-induced proteins are elevated in blood samples of patients with chemically or virally induced chronic fatigue syndrome
17. Diagnosis and treatment of mycoplasmal infections in Persian Gulf War illness and CFIDS patients
18. Role of mycoplasma infections in fatigue illness: Chronic fatigue, fibromyalgia syndromes, Gulf War illness and rheumatoid arthritis
19. Chronic fatigue syndrome: Clinical condition associated with immune activation
20. +T cells
21. Pilot study of the effects of thymus protein on elevated Epstein-Barr virus titers
22. Fibromyalgia and its relation to chronic fatigue syndrome. Viral illness and immune abnormalities
23. A small randomized, placebo-controlled trial of the use of antiviral therapy for patients with chronic fatigue syndrome